These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1394930)

  • 1. Endogenous fibrinolytic system in chronic large-vessel thromboembolic pulmonary hypertension.
    Olman MA; Marsh JJ; Lang IM; Moser KM; Binder BR; Schleef RR
    Circulation; 1992 Oct; 86(4):1241-8. PubMed ID: 1394930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
    Siegbahn A; Ruusuvaara L
    Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baseline fibrinolytic state and the risk of future venous thrombosis. A prospective study of endogenous tissue-type plasminogen activator and plasminogen activator inhibitor.
    Ridker PM; Vaughan DE; Stampfer MJ; Manson JE; Shen C; Newcomer LM; Goldhaber SZ; Hennekens CH
    Circulation; 1992 May; 85(5):1822-7. PubMed ID: 1572039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypofibrinolysis in patients with a history of idiopathic deep vein thrombosis and/or pulmonary embolism.
    Grimaudo V; Bachmann F; Hauert J; Christe MA; Kruithof EK
    Thromb Haemost; 1992 Apr; 67(4):397-401. PubMed ID: 1631786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Decreased fibrinolytic capacity in coronary patients by increased plasminogen activator inhibitor activity].
    Ihnken K; Speiser W; Müller-Berghaus G; Beyersdorf F; Schlepper M; Satter P
    Helv Chir Acta; 1992 Jan; 58(4):503-8. PubMed ID: 1582860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasminogen activators t-PA, u-PA and its inhibitor (PAI) in normal males and females.
    Koh SC; Yuen R; Viegas OA; Chua SE; Ng BL; Sen DK; Ratnam SS
    Thromb Haemost; 1991 Nov; 66(5):581-5. PubMed ID: 1803623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increase in thrombomodulin concentrations after pulmonary thromboendarterectomy in chronic thromboembolic pulmonary hypertension.
    Sakamaki F; Kyotani S; Nagaya N; Sato N; Oya H; Nakanishi N
    Chest; 2003 Oct; 124(4):1305-11. PubMed ID: 14555559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinogen, t-PA, and PAI-1 plasma levels in patients with pulmonary hypertension.
    Huber K; Beckmann R; Frank H; Kneussl M; Mlczoch J; Binder BR
    Am J Respir Crit Care Med; 1994 Oct; 150(4):929-33. PubMed ID: 7921465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tissue-type plasminogen activator and its inhibitor (PAI-1) in plasma in cases of non-insulin-dependent diabetes mellitus (NIDDM)].
    Jokaji H; Asakura H; Saito M; Uotani C; Kumabashiri I; Morishita E; Yamazaki M; Matsuda T
    Nihon Ronen Igakkai Zasshi; 1990 Nov; 27(6):699-705. PubMed ID: 2127812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrinolysis in normal subjects--comparison between plasminogen activator inhibitor and other components of the fibrinolytic system.
    Nicoloso G; Hauert J; Kruithof EK; Van Melle G; Bachmann F
    Thromb Haemost; 1988 Apr; 59(2):299-303. PubMed ID: 3133812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic synthesis and clearance of components of the fibrinolytic system in healthy volunteers and in patients with different stages of liver cirrhosis.
    Huber K; Kirchheimer JC; Korninger C; Binder BR
    Thromb Res; 1991 Jun; 62(5):491-500. PubMed ID: 1910213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hypofibrinolysis after venous occlusion in patients treated with long-term hemodialysis].
    Opatrný K; Vít L; Opatrná S; Sulková S; Bodláková B
    Cas Lek Cesk; 1994 May; 133(11):346-9. PubMed ID: 8004664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tissue plasminogen activator (T-PA) and tissue plasminogen activator inhibitor (PAI-1) in patients after head injury].
    Beuth W; Kotschy M; Kasprzak HA; Rość D; Osiński P; Sniegocki M
    Neurol Neurochir Pol; 1996; 30(3):427-34. PubMed ID: 8965977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased plasma fibrinolysis and tissue-type plasminogen activator/tissue-type plasminogen activator inhibitor ratios after ethanol withdrawal in chronic alcoholics.
    Delahousse B; Maillot F; Gabriel I; Schellenberg F; Lamisse F; Gruel Y
    Blood Coagul Fibrinolysis; 2001 Jan; 12(1):59-66. PubMed ID: 11229828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperfibrinolysis in alcoholic cirrhosis: relative plasminogen activator inhibitor type 1 deficiency.
    Ferguson JW; Helmy A; Ludlam C; Webb DJ; Hayes PC; Newby DC
    Thromb Res; 2008; 121(5):675-80. PubMed ID: 17870147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in plasminogen activator inhibitor 1 and tissue-type plasminogen activator during exercise in patients with coronary artery disease.
    Rydzewski A; Sakata K; Kobayashi A; Yamazaki N; Urano T; Takada Y; Takada A
    Haemostasis; 1990; 20(5):305-12. PubMed ID: 2127039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrinolysis and coagulation in patients with infectious disease and sepsis.
    Philippé J; Offner F; Declerck PJ; Leroux-Roels G; Vogelaers D; Baele G; Collen D
    Thromb Haemost; 1991 Mar; 65(3):291-5. PubMed ID: 1904655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of fibrinolytic capacity by a combined assay system for tissue-type plasminogen activator antigen and function using monoclonal anti-tissue-type plasminogen activator antibodies.
    Wojta J; Turcu L; Wagner OF; Korninger C; Binder BR
    J Lab Clin Med; 1987 Jun; 109(6):665-71. PubMed ID: 3108431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coagulation and fibrinolytic parameters in patients with pulmonary hypertension.
    Altman R; Scazziota A; Rouvier J; Gurfinkel E; Favaloro R; Perrone S; Fareed J
    Clin Cardiol; 1996 Jul; 19(7):549-54. PubMed ID: 8818435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue plasminogen activator release in chronic venous hypertension due to heart failure.
    Keber I; Keber D; Stegnar M; Vene N
    Thromb Haemost; 1992 Sep; 68(3):321-4. PubMed ID: 1440498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.